- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00675467
Palliative Care and Symptom Management for the Pediatric Oncology Patient
The goal of this study is to learn about the communication, decision-making, symptom management, emotional adjustment, and spiritual needs of parents and pediatric patients treated at the Children's Cancer Hospital at M. D. Anderson (MCACC).
Primary Objectives:
- Determine the palliative care service needs of pediatric cancer patients and their parents, including communication, decision-making, symptom management, emotional and spiritual support when receiving treatment for early cancer, treatment for advanced disease, and treatment in the end-of-life period.
- Identify intra-group differences in the categories listed in Objective 1 for pediatric cancer patients receiving treatment (a) for early cancer, (b) for advanced disease, and (c) at end-of-life.
Secondary Objectives:
1. Inform the development of a Pediatric Palliative Care Program at the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center (MCACC or MDACC) based on identified needs as determined by primary study aims 1 and 2.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
PARENT:
The Focus Group:
If you agree to take part in this study, you will attend a 1 1/2 hour group session with 3-9 other caregivers. The group will be led by a group leader and an assistant. The group leader will ask questions to the group about communication, decision-making, symptom management, emotional adjustment, and spirituality experiences and needs during your child's treatment. If you have a child who is also taking part in this study, you will meet separately from your child.
At the time of your arrival and before the beginning of the focus group session, you will be asked to complete a questionnaire. You will be asked about you and your child's age, sex, where you live, your religion (if any), your ethnicity and race, and if there are other children in the family. You will be asked about when you found out your child had cancer, the type of cancer, and when the cancer got worse or came back (if applicable). You will be asked whether others have shared parenting responsibilities, your education level, and if you work and what type of work you do. The questionnaire will take about 5 minutes to complete.
Audiotapes/Transcripts:
The assistant will take notes and the session will be recorded on an audiotape. All audiotapes will be stored in locked cabinets maintained by the study chair. The audiotapes will be destroyed once the study and analyses are complete.
The audiotape will be recorded onto paper "transcripts". The completed focus group transcriptions will be placed in a database secured with a password and identification protected. Transcribed results will have all identifiable markers removed and kept in the investigators' locked files. Only the researchers will be able to view the transcriptions.
Length of Study:
Your participation on this study is complete once you finish the group meeting.
PEDIATRIC PARTICIPANT:
The Focus Group:
If you agree to take part in this study, you will go to a 1 1/2 hour group session with 3-9 other patients. The group will be led by a group leader and an assistant. The group leader will ask questions to the group about who you talk with about the disease, how you make a decision, how you manage any symptoms you may have, how you are feeling about the disease, and how religion has helped you during your treatment. If your parent is also taking part in this study, you will meet separately from your parent.
At the time of your arrival and before the beginning of the focus group session, your parent will be asked to complete a questionnaire. Your parent will be asked about their age and sex, your age and sex, where you live, your religion (if any), your ethnicity and race, and if there are other children in the family. Your parent will be asked when they found out you had cancer, the type of cancer, and when the cancer got worse or came back (if applicable). Your parent will be asked whether others have shared parenting responsibilities, their education level, and if they work and about the type of work they do. The questionnaire will take about 5 minutes to complete.
Audiotapes/Transcripts:
The assistant will take notes and the session will be recorded on an audiotape. All audiotapes will be stored in locked cabinets taken care of by the study chair. The audiotapes will be destroyed once the study is over and the researchers have finished looking at the information.
The audiotape will be recorded onto paper "transcripts". The completed focus group transcriptions will be placed in a database secured with a password and identification protected. Any personal information about you will be removed from these papers and the papers will be kept in the investigators' locked files. Only the researchers will be able to view the transcriptions.
Length of Study:
Your participation on this study is over once you complete the focus group.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- University of Texas MD Anderson Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Inclusion for Children:
- 10-18 years of age
- MD Anderson Children's Cancer Center (MCACC) cancer patient
- receiving anti-cancer treatment for disease that is not recurrent or metastatic for cancer diagnosed in the past 3-12 mos or receiving anti-cancer treatment for recurrent or metastatic cancer diagnosed within the past 3-12 months
- speak & understand English
- reside in the Greater Houston area
- provide IRB-approved pediatric assent or informed consent, as age appropriate
- if < 18 years of age, provide Internal Review Board (IRB)-approved parental permission
- child's eligibility is not contingent upon parent's decision to participate
Inclusion for parents:
- self-identified parent(s) that has(have) a child eligible for study, per the inclusion and exclusion criteria noted above or has had a child (0-18 yrs of age at time of death) treated for cancer at MCACC who has died in the last 1 to 2 years
- speak and understand English
- reside in the Houston metropolitan area
- provide IRB-approved informed consent
- attend different focus groups if more than one eligible parent per child (max 2 parents per child)
- parent's eligibility is not contingent upon the child's decision to participate
Exclusion Criteria:
Exclusion for Children:
- have cognitive impairment, developmental delay, or emotional distress that would limit participation in a group discussion, as determined by the clinical judgment of the investigator
- younger than 10 years or older than 18 years of age
Exclusion for Caregiver:
- have cognitive impairment, developmental delay, or emotional distress that would limit participation in a group discussion, as determined by the clinical judgment of the investigator.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group 1
Early cancer group-children ages 10-13 years
|
A 1 1/2 hour group session with other parents/caregivers.
A 1 1/2 hour group session with other pediatric patients.
|
Group 2
Early cancer group-children ages 14 to 18 years
|
A 1 1/2 hour group session with other parents/caregivers.
A 1 1/2 hour group session with other pediatric patients.
|
Group 3
Early cancer group-parents of patients ages 10-18 years
|
A 1 1/2 hour group session with other parents/caregivers.
A 1 1/2 hour group session with other pediatric patients.
|
Group 4
Advanced cancer group-children ages 10-13 years
|
A 1 1/2 hour group session with other parents/caregivers.
A 1 1/2 hour group session with other pediatric patients.
|
Group 5
Advanced cancer group-children ages 14-18 years
|
A 1 1/2 hour group session with other parents/caregivers.
A 1 1/2 hour group session with other pediatric patients.
|
Group 6
Advanced cancer group-parents of children ages 10-18 years
|
A 1 1/2 hour group session with other parents/caregivers.
A 1 1/2 hour group session with other pediatric patients.
|
Group 7
End of life group - parents of children ages birth to 18 years of age at time of death
|
A 1 1/2 hour group session with other parents/caregivers.
A 1 1/2 hour group session with other pediatric patients.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Palliative Care Service Needs of Pediatric Cancer Patients + Their Parents
Time Frame: 3 Years
|
Qualitative data collection.
|
3 Years
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2007-0054
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Cancers
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); University of Minnesota; Children's Oncology...CompletedOncology | Pediatric CancersUnited States
-
National Cancer Institute (NCI)CompletedPediatric Leukemia | Other Pediatric CancersUnited States
-
Chinese University of Hong KongQueen Elizabeth Hospital, Hong Kong; Prince of Wales Hospital, Shatin, Hong... and other collaboratorsCompleted
-
M.D. Anderson Cancer CenterCompleted
-
Centennial CollegeStollery Children's Hospital; SickKids Foundation; Canadian Institute of Natural...UnknownDepression | Stress | Anxiety | Pediatric CancersCanada
-
National Cancer Institute (NCI)WithdrawnPediatric Leukemia | Pediatric Brain Neoplasms | Other Pediatric Cancers
-
National Cancer Institute (NCI)Enrolling by invitationSolid Tumors | Hematologic Malignancies | Pediatric CancersUnited States
-
M.D. Anderson Cancer CenterTerminated
-
Agenus Inc.CompletedAdvanced Solid Cancers | Advanced Solid Cancers Refractory to PD-1United States
-
University Hospital, RouenCompletedBreast Cancer | Colorectal Cancer | Ovarian Cancer | Pediatric Cancers | Multiple Primary Malignant TumoursFrance
Clinical Trials on Focus Group - Parent/Caregiver
-
Emory UniversityNational Institute on Aging (NIA)CompletedDementia | Caregiver BurnoutUnited States
-
Rush University Medical CenterNational Institute on Aging (NIA)CompletedLewy Body Disease | Dementia With Lewy Bodies | Parkinson Disease DementiaUnited States
-
Karolinska InstitutetOregon Social Learning CenterCompleted
-
Queen's University, BelfastCompletedAge Related Macular DegenerationUnited Kingdom
-
Western Oregon UniversityHRSA/Maternal and Child Health BureauCompleted
-
Western Oregon UniversityHRSA/Maternal and Child Health BureauCompleted
-
Stanford UniversityNational Institute of Mental Health (NIMH)Completed
-
Teesside UniversitySouth Tees Hospitals NHS Foundation TrustNot yet recruitingOveractive Bladder | Urinary Incontinence | Benign Prostatic Hyperplasia | Urinary Tract Infections | Urinary Retention | Underactive Bladder
-
University of Kansas Medical CenterEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPregnancy RelatedUnited States
-
Beth FosterThe Hospital for Sick Children; University of Pittsburgh; Seattle Children's... and other collaboratorsCompletedTeen Adherence in KidnEy Transplant, Improving Tracking To Optimize Outcomes (Stage 1) (TAKE-IT TOO)Medication AdherenceCanada, United States